ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,966, issued on Sept. 22, was assigned to FOGHORN THERAPEUTICS INC. (Watertown, Mass.).

"BRM/BRG1 inhibitors and uses thereof" was invented by Rishi G. Vaswani (Lexington, Mass.), Neville John Anthony (Northborough, Mass.), David Simon Millan (Stow, Mass.), Shawn E.R. Schiller (Haverhill, Mass.), Kevin J. Wilson (Roslindale, Mass.) and David S. Huang (Watertown, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The compounds disclosed herein may be inhibitors of BRG1 (Brahma-related gene-1) and/or BRM (Brahma). The compounds or pharmaceutically acceptable salts thereof are useful for the treatment of disorders associated with an alteration in a B...